Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

Delayed Data
As of 3:59pm ET
 -0.36 / -1.57%
Today’s Change
Today|||52-Week Range
AstraZeneca Stock Rising in '17: What's Working in its Favor?
11:38am / Zacks.com - Paid Partner Content
Biotechs Remain the Best Place For Stock Picking
Mar 20 / TheStreet.com - Paid Partner Content
4 Biotech Stocks to Watch
Mar 22 / GuruFocus News - Paid Partner Content
Biotech Premarket Movers:
Mar 20 / TheStreet.com - Paid Partner Content
Biotech Stock Roundup: Amgen Down on Repatha Data, Nektar Surges on Pain Results
Mar 22 / Zacks.com - Paid Partner Content
New painkiller aims to avoid buzz that feeds addiction
Mar 20 / FT.com - Paid Partner Content
Nektar's Pain Drug Positive in Phase III Study; Shares Gain
Mar 21 / Zacks.com - Paid Partner Content
Nektar Addiction-Resistant Opioid Reduces Chronic Pain in Late-Stage Study
Mar 20 / TheStreet.com - Paid Partner Content
Rev's Forum: Don't Just Sit There, Do Something!
Mar 21 / TheStreet.com - Paid Partner Content